NASDAQ
Neuphoria Therapeutics Inc. (NEUP) has a free cash flow growth of 39.84% as of Friday, May 29, 2026. This represents a 80.29% decrease compared to its 12-month average of 202.16%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.